Abcellera Biologics Inc (ABCL) Stock Price, Quote & News

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 559 9005

Website: www.abcellera.com

Address:

150 W 4th Avenue, Vancouver, Canada

UncleTomFlorida Apr. 25 at 2:15 PM

$ABCL

0 · Reply

UncleTomFlorida Apr. 25 at 4:35 AM

$ABCL $40 by ……? https://x.com/JackPrescottX/status/2047791083686682864?s=20

0 · Reply

DeMampCamp Apr. 24 at 8:12 PM

$ABCL I'm happy that we closed above the 200ma, but less than thrilled that they hammered it down from $4.29. Over 9.3 million in volume today, I'm looking for $5+ next week if the overall markets can cooperate! Cheers everyone, have a wonderful weekend!

2 · Reply

bonecrack_benny Apr. 24 at 6:43 PM

$ABCL Amazing.

1 · Reply

Art_BunyaaHa Apr. 24 at 6:28 PM

$ABCL

0 · Reply

JennyRowes Apr. 24 at 5:59 PM

$ABCL higher and higher on higher volume.

0 · Reply

DeMampCamp Apr. 24 at 5:50 PM

$ABCL Shorts trying so hard to not let this get out of hand!

1 · Reply

NorthShoreTrader2021 Apr. 24 at 5:49 PM

$ABCL Imagine shorting $ABCL and watching it keep climbing day after day. 📈 That's the reality for shorts right now — significant losses piling up as AbCellera's price grinds higher and they refuse to cover. Every uptick is a squeeze tightening around their positions. Check the $ABCL charts. The price action speaks for itself. Shorts are on the wrong side of this trade and the pressure is only building. 🔥

1 · Reply

tradersunion353 Apr. 24 at 5:30 PM

$ABCL Yes you need to keep moving up.. you need to benefit long term investors... Ned $12 please..

1 · Reply

Ckkung71 Apr. 24 at 4:55 PM

$ABCL up,down,up,down,up,down…

0 · Reply

AbCellera Biologics Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference

Apr 20, 2026, 9:00 AM EDT - 5 days ago

AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

Apr 1, 2026, 4:05 PM EDT - 23 days ago

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026

Mar 17, 2026, 4:30 PM EDT - 5 weeks ago

AbCellera Biologics Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

Mar 4, 2026, 9:50 AM EST - 7 weeks ago

AbCellera Biologics Transcript: TD Cowen 46th Annual Health Care Conference

Feb 24, 2026, 5:00 PM EST - 2 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 4:05 PM EST - 2 months ago

AbCellera Reports Full Year 2025 Business Results

Feb 11, 2026, 4:05 PM EST - 2 months ago

AbCellera to Present at Upcoming Investor Conferences in March and April 2026

Jan 22, 2026, 4:05 PM EST - 3 months ago

AbCellera to Report Full Year 2025 Financial Results on February 24, 2026

Jan 14, 2026, 6:45 PM EST - 3 months ago

AbCellera Biologics Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 9:00 AM EST - 3 months ago

AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause

Dec 18, 2025, 9:00 AM EST - 4 months ago

AbCellera and Bruker Reach Global Settlement of Patent Litigation

Dec 8, 2025, 4:05 PM EST - 4 months ago

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Dec 3, 2025, 8:00 AM EST - 5 months ago

AbCellera Biologics Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 13, 2025, 8:00 AM EST - 5 months ago

AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference

Nov 10, 2025, 9:00 AM EST - 5 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:05 PM EST - 6 months ago

AbCellera Reports Q3 2025 Business Results

Oct 7, 2025, 4:05 PM EDT - 7 months ago

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

Sep 29, 2025, 4:05 PM EDT - 7 months ago

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

Sep 10, 2025, 9:07 AM EDT - 8 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 5, 2025, 9:30 AM EDT - 8 months ago

AbCellera Biologics Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 27, 2025, 9:00 AM EDT - 8 months ago

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

Aug 12, 2025, 4:05 PM EDT - 9 months ago

AbCellera to Participate at Upcoming Investor Conferences in September

Aug 7, 2025, 5:00 PM EDT - 9 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:05 PM EDT - 9 months ago

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

Jul 7, 2025, 4:05 PM EDT - 10 months ago

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

Jun 9, 2025, 10:40 AM EDT - 11 months ago

AbCellera Biologics Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 30, 2025, 1:00 PM EDT - 11 months ago

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

May 14, 2025, 5:00 PM EDT - 1 year ago

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

May 12, 2025, 3:30 PM EDT - 1 year ago

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

May 9, 2025, 7:30 PM EDT - 1 year ago

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results

May 5, 2025, 9:30 AM EDT - 1 year ago

AbCellera Biologics Transcript: Bloom Burton & Co. Healthcare Investor Conference 2025

Apr 29, 2025, 3:00 PM EDT - 1 year ago

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

Apr 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in May and June

Apr 3, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

Mar 25, 2025, 4:30 PM EDT - 1 year ago

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Mar 19, 2025, 1:30 PM EDT - 1 year ago

AbCellera Biologics Transcript: KeyBanc Annual Health Care Forum

Mar 3, 2025, 2:30 PM EST - 1 year ago

AbCellera Biologics Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results

Feb 11, 2025, 4:05 PM EST - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in March

Jan 21, 2025, 4:05 PM EST - 1 year ago

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 13, 2025, 9:00 AM EST - 1 year ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

Dec 3, 2024, 2:30 PM EST - 1 year ago

AbCellera Biologics Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 21, 2024, 4:05 PM EST - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in December and January

Nov 19, 2024, 11:30 AM EST - 1 year ago

AbCellera Biologics Transcript: Jefferies London Healthcare Conference 2024

Nov 18, 2024, 11:30 AM EST - 1 year ago

AbCellera Biologics Transcript: Stifel 2024 Healthcare Conference

Nov 7, 2024, 10:05 AM EST - 1 year ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results

Oct 22, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in November 2024

Oct 4, 2024, 9:00 AM EDT - 1 year ago

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

Sep 26, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

Sep 17, 2024, 11:30 AM EDT - 1 year ago

AbCellera Biologics Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 5, 2024, 3:00 PM EDT - 1 year ago

AbCellera Biologics Transcript: 2024 Wells Fargo Healthcare Conference

Aug 29, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in September

Aug 20, 2024, 9:45 AM EDT - 1 year ago

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

GLOB AVDX LRN PGRU

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results

Jul 31, 2024, 9:00 AM EDT - 1 year ago

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

Jun 25, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

Jun 10, 2024, 3:20 PM EDT - 2 years ago

AbCellera Biologics Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024, 4:05 PM EDT - 2 years ago

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results

May 1, 2024, 9:00 AM EDT - 2 years ago

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies

Apr 16, 2024, 10:00 AM EDT - 2 years ago

AbCellera Biologics Transcript: Bloom Burton & Co. Healthcare Investor Conference

Apr 8, 2024, 12:05 PM EDT - 2 years ago

AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024

Apr 3, 2024, 4:05 PM EDT - 2 years ago

AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 20, 2024, 11:15 AM EDT - 2 years ago

AbCellera Biologics Transcript: KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Mar 19, 2024, 4:05 PM EDT - 2 years ago

AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024

Mar 11, 2024, 9:00 AM EDT - 2 years ago

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions

BIIB

Mar 5, 2024, 4:30 PM EST - 2 years ago

AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024

Mar 5, 2024, 2:50 PM EST - 2 years ago

AbCellera Biologics Transcript: TD Cowen 44th Annual Health Care Conference 2024

Feb 23, 2024, 4:30 PM EST - 2 years ago

AbCellera Announces Resignation of Board Member

Feb 20, 2024, 5:00 PM EST - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2023

Jan 10, 2024, 5:15 PM EST - 2 years ago

AbCellera Biologics Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Nov 30, 2023, 9:30 AM EST - 2 years ago

AbCellera Biologics Transcript: Piper Sandler 35th Annual Healthcare Conference

Nov 14, 2023, 11:30 AM EST - 2 years ago

AbCellera Biologics Transcript: Jefferies London Healthcare Conference 2023

Nov 2, 2023, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q3 2023

Aug 3, 2023, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2023

Jun 13, 2023, 4:20 PM EDT - 3 years ago

AbCellera Biologics Transcript: Goldman Sachs 44th Annual Global Healthcare Conference

May 4, 2023, 5:00 PM EDT - 3 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2023

Feb 21, 2023, 5:00 PM EST - 3 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2022

Jan 11, 2023, 5:15 PM EST - 3 years ago

AbCellera Biologics Transcript: JPMorgan Healthcare Conference

Nov 8, 2022, 5:00 PM EST - 3 years ago

AbCellera Biologics Earnings Call Transcript: Q3 2022

Aug 9, 2022, 5:00 PM EDT - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2022

May 10, 2022, 8:52 AM EDT - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2022

Feb 24, 2022, 9:23 AM EST - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2021

Nov 8, 2021, 7:00 PM EST - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q3 2021

Aug 12, 2021, 12:02 PM EDT - 5 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2021

May 13, 2021, 9:46 AM EDT - 5 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2021

Mar 29, 2021, 9:46 AM EDT - 5 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2020

UncleTomFlorida Apr. 25 at 2:15 PM

$ABCL

0 · Reply

UncleTomFlorida Apr. 25 at 4:35 AM

$ABCL $40 by ……? https://x.com/JackPrescottX/status/2047791083686682864?s=20

0 · Reply

DeMampCamp Apr. 24 at 8:12 PM

2 · Reply

bonecrack_benny Apr. 24 at 6:43 PM

$ABCL Amazing.

1 · Reply

Art_BunyaaHa Apr. 24 at 6:28 PM

$ABCL

0 · Reply

JennyRowes Apr. 24 at 5:59 PM

$ABCL higher and higher on higher volume.

0 · Reply

DeMampCamp Apr. 24 at 5:50 PM

$ABCL Shorts trying so hard to not let this get out of hand!

1 · Reply

NorthShoreTrader2021 Apr. 24 at 5:49 PM

1 · Reply

tradersunion353 Apr. 24 at 5:30 PM

$ABCL Yes you need to keep moving up.. you need to benefit long term investors... Ned $12 please..

1 · Reply

Ckkung71 Apr. 24 at 4:55 PM

$ABCL up,down,up,down,up,down…

0 · Reply

DragonAlgo Apr. 24 at 4:53 PM

🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2026-05-15 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $0.53 Stop: $0.38 TP1: $0.68 TP2: $0.89 TP3: $1.26 Volatility regime is active. 🔗 https://dragonalgo.com

0 · Reply